These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


135 related items for PubMed ID: 1414270

  • 21. Reductions in acetylcholine and nicotine binding in several degenerative diseases.
    Whitehouse PJ, Martino AM, Marcus KA, Zweig RM, Singer HS, Price DL, Kellar KJ.
    Arch Neurol; 1988 Jul; 45(7):722-4. PubMed ID: 3390025
    [Abstract] [Full Text] [Related]

  • 22. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
    Mufson EJ, Jaffar S, Levey AI.
    J Comp Neurol; 1998 Mar 16; 392(3):313-29. PubMed ID: 9511920
    [Abstract] [Full Text] [Related]

  • 23. Cholinergic control in the floccular cerebellum of the rabbit.
    van der Steen J, Tan HS.
    Prog Brain Res; 1997 Mar 16; 114():335-45. PubMed ID: 9193153
    [No Abstract] [Full Text] [Related]

  • 24. Choline acetyltransferase and acetylcholinesterase abnormalities in senile dementia: importance of biochemical measurements in human post-mortem brain specimens.
    Sorbi S, Antuono P, Amaducci L.
    Ital J Neurol Sci; 1980 Mar 16; 1(2):75-83. PubMed ID: 7040296
    [Abstract] [Full Text] [Related]

  • 25. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.
    Gilmor ML, Erickson JD, Varoqui H, Hersh LB, Bennett DA, Cochran EJ, Mufson EJ, Levey AI.
    J Comp Neurol; 1999 Sep 06; 411(4):693-704. PubMed ID: 10421878
    [Abstract] [Full Text] [Related]

  • 26. Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group.
    DeKosky ST, Harbaugh RE, Schmitt FA, Bakay RA, Chui HC, Knopman DS, Reeder TM, Shetter AG, Senter HJ, Markesbery WR.
    Ann Neurol; 1992 Nov 06; 32(5):625-32. PubMed ID: 1360195
    [Abstract] [Full Text] [Related]

  • 27. Choline acetyltransferase activity in omental tissue.
    Goldsmith HS, Marquis JK, Siek G.
    Br J Neurosurg; 1987 Nov 06; 1(4):463-6. PubMed ID: 3268142
    [Abstract] [Full Text] [Related]

  • 28. Cholinergic markers in the cortex and hippocampus of some animal species and their correlation to Alzheimer's disease.
    Orta-Salazar E, Cuellar-Lemus CA, Díaz-Cintra S, Feria-Velasco AI.
    Neurologia; 2014 Oct 06; 29(8):497-503. PubMed ID: 23433740
    [Abstract] [Full Text] [Related]

  • 29. Selective loss of central cholinergic neurons in Alzheimer's disease.
    Davies P, Maloney AJ.
    Lancet; 1976 Dec 25; 2(8000):1403. PubMed ID: 63862
    [No Abstract] [Full Text] [Related]

  • 30. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.
    Kellar KJ, Whitehouse PJ, Martino-Barrows AM, Marcus K, Price DL.
    Brain Res; 1987 Dec 08; 436(1):62-8. PubMed ID: 3690354
    [Abstract] [Full Text] [Related]

  • 31. Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease.
    Karami A, Eyjolfsdottir H, Vijayaraghavan S, Lind G, Almqvist P, Kadir A, Linderoth B, Andreasen N, Blennow K, Wall A, Westman E, Ferreira D, Kristoffersen Wiberg M, Wahlund LO, Seiger Å, Nordberg A, Wahlberg L, Darreh-Shori T, Eriksdotter M.
    Alzheimers Dement; 2015 Nov 08; 11(11):1316-28. PubMed ID: 25676388
    [Abstract] [Full Text] [Related]

  • 32. The cholinergic system of the human hindbrain studied by choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry.
    Mizukawa K, McGeer PL, Tago H, Peng JH, McGeer EG, Kimura H.
    Brain Res; 1986 Jul 30; 379(1):39-55. PubMed ID: 2427162
    [Abstract] [Full Text] [Related]

  • 33. Cholinergic markers in elderly patients with early signs of Alzheimer disease.
    Davis KL, Mohs RC, Marin D, Purohit DP, Perl DP, Lantz M, Austin G, Haroutunian V.
    JAMA; 1999 Apr 21; 281(15):1401-6. PubMed ID: 10217056
    [Abstract] [Full Text] [Related]

  • 34. Endogenous inhibitors of human choline acetyltransferase present in Alzheimer's brain: preliminary observation.
    Singh I, Xu C, Pettegrew JW, Kanfer JN.
    Neurobiol Aging; 1994 Apr 21; 15(5):643-9. PubMed ID: 7824057
    [Abstract] [Full Text] [Related]

  • 35. Challenging the cholinergic hypothesis in Alzheimer disease.
    Davies P.
    JAMA; 1999 Apr 21; 281(15):1433-4. PubMed ID: 10217061
    [No Abstract] [Full Text] [Related]

  • 36. [Abnormalities of neurotransmitters in Alzheimer's disease. Disturbance of the acetylcholine system and nucleus basalis of Meynert].
    Arai H, Iizuka R.
    Nihon Rinsho; 1988 Jul 21; 46(7):1491-5. PubMed ID: 3221455
    [No Abstract] [Full Text] [Related]

  • 37. Neurochemical characteristics of early and late onset types of Alzheimer's disease.
    Rossor MN, Iversen LL, Reynolds GP, Mountjoy CQ, Roth M.
    Br Med J (Clin Res Ed); 1984 Mar 31; 288(6422):961-4. PubMed ID: 6142750
    [Abstract] [Full Text] [Related]

  • 38. Cholinergic markers in Alzheimer disease.
    Bartus RT, Emerich DF.
    JAMA; 1999 Dec 15; 282(23):2208-9. PubMed ID: 10605966
    [No Abstract] [Full Text] [Related]

  • 39. [The cholinergic system in the early development of chickens. 1. Choline acetyltransferase and acetylcholinesterase as the key regulators of acetylcholine metabolism].
    Laasberg TA.
    Ontogenez; 1988 Dec 15; 19(6):645-51. PubMed ID: 3231404
    [Abstract] [Full Text] [Related]

  • 40. Basal forebrain cholinergic neurons are selectively vulnerable to AMPA/kainate receptor-mediated neurotoxicity.
    Weiss JH, Yin HZ, Choi DW.
    Neuroscience; 1994 Jun 15; 60(3):659-64. PubMed ID: 7523984
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.